Tristetraprolin Mediates Anti-Inflammatory Effect of Carbon Monoxide against DSS-Induced Colitis

Endogenous carbon monoxide (CO) exerts anti-inflammatory effects. Tristetraprolin (TTP) is known to destabilize pro-inflammatory transcripts. Here we found that exogenous CO enhanced the decay of TNF-α mRNA and suppressed TNF-α expression in LPS-activated macrophages from wild-type (WT) mice. However, TTP deficiency abrogated the effects of exogenous CO. While CO treatment prior to DSS administration in WT mice significantly reduced inflammatory cytokine levels and colitis, it failed to reduce the pro-inflammatory cytokine levels and colitis in TTP knockout (KO) mice. Our results demonstrate that TTP is a key factor mediating the anti-inflammatory action of CO in DSS-induced colitis.

[1]  P. Blackshear,et al.  Tristetraprolin regulation of interleukin 23 mRNA stability prevents a spontaneous inflammatory disease , 2013, The Journal of experimental medicine.

[2]  I. Hofacker,et al.  Tristetraprolin-driven regulatory circuit controls quality and timing of mRNA decay in inflammation , 2011, Molecular systems biology.

[3]  Y. Naito,et al.  Carbon Monoxide Liberated from Carbon Monoxide-Releasing Molecule Exerts an Anti-inflammatory Effect on Dextran Sulfate Sodium-Induced Colitis in Mice , 2011, Digestive Diseases and Sciences.

[4]  Hyo Jeong Kim,et al.  Tristetraprolin Mediates Anti-inflammatory Effects of Nicotine in Lipopolysaccharide-stimulated Macrophages* , 2011, The Journal of Biological Chemistry.

[5]  L. Otterbein,et al.  The therapeutic potential of carbon monoxide , 2010, Nature Reviews Drug Discovery.

[6]  G. Dalmasso,et al.  Temporal and Spatial Analysis of Clinical and Molecular Parameters in Dextran Sodium Sulfate Induced Colitis , 2009, PloS one.

[7]  B. Kelsall.  Recent progress in understanding the phenotype and function of intestinal dendritic cells and macrophages , 2008, Mucosal Immunology.

[8]  R. Xavier,et al.  Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.

[9]  A. Sepulveda,et al.  Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1–dependent pathway , 2005, The Journal of experimental medicine.

[10]  A. Choi,et al.  Heme oxygenase-1: from bench to bedside. , 2005, American journal of respiratory and critical care medicine.

[11]  R. Foresti,et al.  Carbon monoxide‐releasing molecules (CO‐RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages , 2005, British journal of pharmacology.

[12]  Xin-Yuan Fu,et al.  Carbon Monoxide Differentially Modulates STAT1 and STAT3 and Inhibits Apoptosis via a Phosphatidylinositol 3-Kinase/Akt and p38 Kinase-dependent STAT3 Pathway during Anoxia-Reoxygenation Injury* , 2005, Journal of Biological Chemistry.

[13]  K. Khabar,et al.  The AU-rich transcriptome: more than interferons and cytokines, and its role in disease. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[14]  Y. Naito,et al.  Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor‐alpha deficient mice , 2003, Journal of gastroenterology and hepatology.

[15]  T. Giese,et al.  Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease , 2002, Virchows Archiv.

[16]  P. Sarathchandra,et al.  Carbon Monoxide-Releasing Molecules: Characterization of Biochemical and Vascular Activities , 2002, Circulation research.

[17]  A. Shyu,et al.  The Double Lives of Shuttling mRNA Binding Proteins , 2000, Cell.

[18]  Garside.  Cytokines in experimental colitis , 1999, Clinical and experimental immunology.

[19]  P. Blackshear,et al.  Feedback Inhibition of Macrophage Tumor Necrosis Factor-α Production by Tristetraprolin , 1998 .

[20]  T. Mayumi,et al.  Proliferative Effect of Dextran Sulfate Sodium (DSS)‐Pulsed Macrophages on T Cells from Mice with DSS‐Induced Colitis and Inhibition of Effect by IgG , 1997, Scandinavian journal of immunology.

[21]  B. Haynes,et al.  A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. , 1996, Immunity.

[22]  C. Elson,et al.  Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. , 1994, Gastroenterology.

[23]  S. Hinuma,et al.  Pretreatment of plastic Petri dishes with fetal calf serum. A simple method for macrophage isolation. , 1979, Journal of immunological methods.

[24]  Y. Naito,et al.  Therapeutic potential of carbon monoxide (CO) for intestinal inflammation. , 2012, Current medicinal chemistry.

[25]  R. Potter,et al.  Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[26]  P. Anderson,et al.  Posttranscriptional mechanisms regulating the inflammatory response. , 2006, Advances in immunology.

[27]  P. Blackshear,et al.  Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. , 1998, Science.

[28]  M. Maines,et al.  The heme oxygenase system: a regulator of second messenger gases. , 1997, Annual review of pharmacology and toxicology.

[29]  T. Ohkusa,et al.  A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. , 1990, Gastroenterology.